ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:41 am Sale | 2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 531,914 1.980% | -2,092,070 (-79.73%) | Filing |
| 2024-02-07 07:09 am Purchase | 2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,623,984 9.990% | 1,370,156 (+109.28%) | Filing |
| 2023-01-25 5:00 pm Purchase | 2023-01-15 | 13G | Syros Pharmaceuticals, Inc. SYRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,253,828 6.040% | 1,253,828 (New Position) | Filing |